SULFISOXAZOLE - Generic Drug Details
What are the generic sources for sulfisoxazole and what is the scope of freedom to operate?
Sulfisoxazole
is the generic ingredient in nine branded drugs marketed by Roche, Mk Labs, Alra, Parke Davis, Ani Pharms, Barr, Heather, Hikma, Impax Labs, Lannett, Lederle, Pharmeral, Purepac Pharm, Rising, Roxane, Valeant Pharm Intl, Vitarine, Watson Labs, Solvay, and Sola Barnes Hind, and is included in twenty-four NDAs. Additional information is available in the individual branded drug profile pages.Summary for SULFISOXAZOLE
| US Patents: | 0 |
| Tradenames: | 9 |
| Applicants: | 20 |
| NDAs: | 24 |
| Raw Ingredient (Bulk) Api Vendors: | 107 |
| Clinical Trials: | 2 |
| DailyMed Link: | SULFISOXAZOLE at DailyMed |
Recent Clinical Trials for SULFISOXAZOLE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Federal University of São Paulo | Phase 4 |
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
| James Graham Brown Cancer Center | Early Phase 1 |
Medical Subject Heading (MeSH) Categories for SULFISOXAZOLE
US Patents and Regulatory Information for SULFISOXAZOLE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche | GANTRISIN PEDIATRIC | sulfisoxazole acetyl | SUSPENSION;ORAL | 009182-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Lederle | SULFISOXAZOLE | sulfisoxazole | TABLET;ORAL | 087649-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmeral | SULFISOXAZOLE | sulfisoxazole | TABLET;ORAL | 084385-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Lannett | SULFISOXAZOLE | sulfisoxazole | TABLET;ORAL | 080085-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
